Chronic immune thrombocytopenic purpura in childhood: Pathogenetic mechanisms and management

Hematology

Volumn 17, Issue 6, 2012, Pages 363-366

  Ferrara, Mara ^a   Bertocco, Fabrizia ^a   Ferrara, Dolores ^a   Capozzi, Laura ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Chronic immune thrombocytopaenic purpura (C ITP); Evans syndrome; Megakaryocytes; Platelet autoantibodies; Splenectomy

Indexed keywords

IMMUNOGLOBULIN; RITUXIMAB; THROMBOCYTE ANTIBODY;

ADOLESCENT; AGE; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD SMEAR; CHILD; CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; HEMOLYTIC ANEMIA; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; MEGAKARYOCYTE; PATHOGENESIS; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SPLENECTOMY; THROMBOCYTE COUNT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; SPLENECTOMY; TREATMENT OUTCOME;

EID: 84869768128     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/1607845412Y.0000000011     Document Type: Article

References (22)

1. Stoll D, Cines DB, Aster RH, Murphi S. Platelet kinetics with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. Blood. 1985;65:584-8.
2. Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter SJ. Mechanism of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J Clin Invest. 1987;80:33-40.
3. McMillian R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2004;103:1364-9.
4. Nugent D, McMillian R, Nichol JL, Slichter SJ. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production. Br J Haematol. 2009;146(6):585-96.
5. McMillian R, Nugent D. The effect of antiplatelet autoantibodies on megakaryocytopoiesis. Int J Hematol. 2005;81(2): 94-9.
6. Liebman HA, Pullarkat V. Diagnosis and management of immune thrombocytopenia in the era of thrombopoietin mimetics. Hematology Am Soc Hematol Educ Program. 2011; 2011:384-90.
7. Gebauer E, Vijatov G. Idiopathic thrombocytopenic purpura in children. Med Pregl. 1998;51(3-4):127-34.
8. Blanchette V, Bolton-Maggs P. Childhood immune thrombocytopenic purpura: diagnosis and management. Pediatr Clin North Am. 2008;55(2):393-420, ix.
9. McMillian R. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective production. Hematol Oncol Clin North Am. 2009;23(6): 1163-75.
10. Imbach P, Tani P, Berchtold W, Blanchette V, Burek-Kozlowsca A, Gerber H, et al. Different form of chronic childhood thrombocytopenic purpura defined by antiplatelet autoantibodies. J Pediatr. 1991;118:535-9.
11. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITp syndrome: a diverse set of disorders with different immune mechanisms. Blood. 2009;113:6511-21.
12. Semple JW. Infections, antigen-presenting cells, T cells, and immune tolerance: their role in the pathogenesis of immune thrombocytopenia. Hematol Onco Clin North Am. 2009;23(6): 1177-1192.
13. Olsson B, Andersson P, Jernas M, Jacobsson S, Carlsson LM, Wadenvik H. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003; 9:1123-4.
14. McMillion R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol. 2000;37(3):239-48.
15. Houwerzijl EJ, Blom NR, van der Want JJL, Esselink MT, Koornstra JJ, Smit JW, et al. Ultrastructural study shows morphological features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood. 2004;103:500-6.
16. Kuter DJ, Gernsheimer TB. Thrombopoietin and platelet production in chronic immune thrombocytopenia. Hematol Oncol Clin North Am. 2009;23:1193-211.
17. Nichol JL. Thrombopoietin levels after chemotherapy and in naturally occurring human diseases. Curr Opin Hematol. 1998; 5:203-8.
18. Bussel JB, Cheng G, Saleh MN, Mayer B, Vasey SY. Incidence of thromboembolic events across eltrombopag clinical trials in chronic immune thrombocytopenia (ITP). Blood. 2010;116:70.
19. Kashif M, Qureshi A, Adil SN, Khurshid M. Successful use of rituximab in Evans syndrome and refractory immune thrombocytopenic purpura. J Pak Med Assoc. 2010;60(1):64-5.
20. Borker A, Choundhary N. Rituximab. Indian Pediatr. 2011; 48(8):627-32.
21. Newland AC, Treleaven JG, Minchinton RM, Waters AH. Highdose intravenous IgG in adults with autoimmune thrombocytopenia. Lancet. 1983;1:84-7.
22. Arnold DM, Dentali F, Crowther MA, Meyer MR, Cook RJ, Sigouin C, et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med. 2007;146:25-33.